LENSAR, Inc. (NASDAQ:LNSR – Get Rating) Director Aimee S. Weisner bought 22,153 shares of the business’s stock in a transaction on Friday, May 19th. The shares were acquired at an average price of $2.59 per share, for a total transaction of $57,376.27. Following the completion of the transaction, the director now owns 37,638 shares in the company, valued at approximately $97,482.42. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
LENSAR Stock Down 4.9 %
Shares of LNSR stock opened at $2.51 on Monday. The stock has a 50-day moving average of $2.60 and a 200-day moving average of $2.97. LENSAR, Inc. has a one year low of $1.90 and a one year high of $7.59.
LENSAR (NASDAQ:LNSR – Get Rating) last posted its earnings results on Monday, May 15th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.13). LENSAR had a negative return on equity of 41.47% and a negative net margin of 51.10%. The business had revenue of $8.25 million for the quarter.
Hedge Funds Weigh In On LENSAR
LENSAR Company Profile
LENSAR, Inc, a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision.
- Get a free copy of the StockNews.com research report on LENSAR (LNSR)
- MarketBeat Week in Review – 5/15 – 5/19
- Applied Materials: Cracks In The Chip Recovery Or Time To Buy?
- Deere & Company Rallies On Farm Equipment Boom, Bullish Outlook
- How Many Roth IRAs Can You Have?
- Why You Should Consider Buying Nvidia Ahead Of Earnings
Receive News & Ratings for LENSAR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LENSAR and related companies with MarketBeat.com's FREE daily email newsletter.